[
  {
    "start": "0",
    "end": "41000"
  },
  {
    "text": "Oh pleasure to be here today it's a phenomenal platform and environment and great to see all these faces tuned in",
    "start": "4360",
    "end": "10210"
  },
  {
    "text": "around the world to engage with us on these topics um can you bring up my slides please as",
    "start": "10210",
    "end": "16059"
  },
  {
    "text": "Kathy mentioned I am indeed the chair of the data and analytics work stream at Kraft but I also have a consulting",
    "start": "16059",
    "end": "22690"
  },
  {
    "text": "practice on the side where I take some of these strategic learnings and bring them to my clients as well that's my",
    "start": "22690",
    "end": "28330"
  },
  {
    "text": "company Oak Health Partners I'm gonna spend some time going through some slides a bit of a different format than",
    "start": "28330",
    "end": "33640"
  },
  {
    "text": "what Richard did but hopefully we can get through some material then have a bit of a discussion on what we've",
    "start": "33640",
    "end": "39490"
  },
  {
    "text": "learned by seeing some of these results so you know as we've been talking about today if I had to distill out that a",
    "start": "39490",
    "end": "45730"
  },
  {
    "start": "41000",
    "end": "102000"
  },
  {
    "text": "conversation so far we can see that in many ways the answers to these problems",
    "start": "45730",
    "end": "51010"
  },
  {
    "text": "come from having a well-formed question a understood and a properly powered data",
    "start": "51010",
    "end": "56620"
  },
  {
    "text": "source and then an analytical method that can bring together those two things to answer and dry drive an insight and",
    "start": "56620",
    "end": "62829"
  },
  {
    "text": "so you know at the Kraft precision medicine program we understand that questions can come from all sorts of",
    "start": "62829",
    "end": "68650"
  },
  {
    "text": "places but we recognize that organizations struggle to understand what are the data sources out there especially in oncology which is a very",
    "start": "68650",
    "end": "75580"
  },
  {
    "text": "fast-moving space and likewise what are the end of the analytical methodologies everything from deep learning and AI",
    "start": "75580",
    "end": "82119"
  },
  {
    "text": "that people hear about to causal methodologies like gns focuses on and so we want to help understand what is that",
    "start": "82119",
    "end": "89140"
  },
  {
    "text": "landscape of practitioners on the analytical methods that we can help point out consumers too so I'm gonna",
    "start": "89140",
    "end": "95590"
  },
  {
    "text": "first that ah double-click on the data sources discussion and show you some of the landscape work that we've done on that",
    "start": "95590",
    "end": "101290"
  },
  {
    "text": "topic so uh in 2016 the first real-world",
    "start": "101290",
    "end": "106659"
  },
  {
    "start": "102000",
    "end": "314000"
  },
  {
    "text": "oncology data landscape was produced I'll show it to you in bigger fine print and bigger print so you don't have to",
    "start": "106659",
    "end": "112570"
  },
  {
    "text": "squint your eyes to see those little bubbles but this was work that was done over the course of 2016 by I think",
    "start": "112570",
    "end": "118869"
  },
  {
    "text": "Sudhir and others at PwC and this really focused on the longitude analogy of data",
    "start": "118869",
    "end": "124030"
  },
  {
    "text": "the openness the funding sources behind data and looked at data sources of all types and sizes and really I think was",
    "start": "124030",
    "end": "131470"
  },
  {
    "text": "extremely exciting because nobody had ever really pulled these data together before had a mass the metadata on these",
    "start": "131470",
    "end": "137050"
  },
  {
    "text": "data sources to be able to what's out there and uh and and how is this space uh evolving and coming",
    "start": "137050",
    "end": "142630"
  },
  {
    "text": "together in 2018 we sought to update that landscape but also to do it a little bit deeper and to look at who's",
    "start": "142630",
    "end": "149350"
  },
  {
    "text": "actually integrating molecular clinical and outcome data in a really comprehensive fashion because all three",
    "start": "149350",
    "end": "156340"
  },
  {
    "text": "of those dimensions are essential to drawing real-world insights from these data we also decide to not focus",
    "start": "156340",
    "end": "162370"
  },
  {
    "text": "necessarily on the smaller data sets because some of those data sets just were underpowered to be useful in and of",
    "start": "162370",
    "end": "168580"
  },
  {
    "text": "themselves and really want to ask who are the major players and where are these major shifts occurring so you can",
    "start": "168580",
    "end": "174280"
  },
  {
    "text": "see here some of the landscape participants that we were able to engage with this is the 2016 results and you",
    "start": "174280",
    "end": "181209"
  },
  {
    "text": "know the name archipelago I think definitely rings a bell here this is a you know word that Paul and Kathy and I",
    "start": "181209",
    "end": "187570"
  },
  {
    "text": "throw around often because there's a lot of little dots here this is you know we think these are data silos in some sense",
    "start": "187570",
    "end": "193480"
  },
  {
    "text": "and we can see here that there are some large ones but sadly in the upper right",
    "start": "193480",
    "end": "198670"
  },
  {
    "text": "hand corner which would represent those data sets that are both longitudinal and you know good long-term outcomes data on",
    "start": "198670",
    "end": "205810"
  },
  {
    "text": "these participants and shared in the public domain there's very few dots up there that upper right-hand quadrant and",
    "start": "205810",
    "end": "211690"
  },
  {
    "text": "so that shows that there's really a lack of publicly accessible data that the world can be consuming that would have",
    "start": "211690",
    "end": "217570"
  },
  {
    "text": "the power to look at answering some of the questions like this answer fun question fundamentally now if we can",
    "start": "217570",
    "end": "224320"
  },
  {
    "text": "fast-forward to the 2018 landscape um this is you know again focused on some of the larger data sets so that's why",
    "start": "224320",
    "end": "230470"
  },
  {
    "text": "some of the smaller dots are missing here but you're seeing here number one there's more large data sets now we have",
    "start": "230470",
    "end": "236140"
  },
  {
    "text": "several data sets that are brought to the 1 million patient sort of limit everybody from Flatiron and IQ via to",
    "start": "236140",
    "end": "242500"
  },
  {
    "text": "coda and and and the Phai precision health group right and so we're seeing",
    "start": "242500",
    "end": "248380"
  },
  {
    "text": "here these massive data sets that are aggregating and coming to bear in this space and it's very exciting we're also",
    "start": "248380",
    "end": "254560"
  },
  {
    "text": "seeing stuff is generally being shifted up in other words more commercial models have been proven viable that you can go",
    "start": "254560",
    "end": "260350"
  },
  {
    "text": "now and either purchase these data sets or access them through subscriptions or academic relationships and therefore",
    "start": "260350",
    "end": "266560"
  },
  {
    "text": "have access to the data assets that are represented on the landscape both of which are really",
    "start": "266560",
    "end": "272080"
  },
  {
    "text": "now we also asked a question to the landscape participants we said would you be willing and able to link your data to",
    "start": "272080",
    "end": "278890"
  },
  {
    "text": "other data sources at the patient level if we provided it you know if you were asked to and we're just interested to",
    "start": "278890",
    "end": "284770"
  },
  {
    "text": "know what was how do people approach this did people kind of have the attitude of hoarding data or were they",
    "start": "284770",
    "end": "290590"
  },
  {
    "text": "open to aggregating and adding data together and what we found nicely was actually that many organizations said",
    "start": "290590",
    "end": "297220"
  },
  {
    "text": "that they were willing and open to providing a link at the patient level to other data sources",
    "start": "297220",
    "end": "302320"
  },
  {
    "text": "now the technicalities of how that gets worked at and of course the contracting of how that gets worked out is beyond",
    "start": "302320",
    "end": "307930"
  },
  {
    "text": "the scope of what we pursued but the attitude of openness seems to be sherry you know evolving as well um and so you",
    "start": "307930",
    "end": "316630"
  },
  {
    "start": "314000",
    "end": "443000"
  },
  {
    "text": "know a few observations I just want to call out specifically on what we saw in these data number one was that we saw about a 25% median increase in the size",
    "start": "316630",
    "end": "324400"
  },
  {
    "text": "the data assets that were represented on the data asset and like I said a number of them have surpassed a 1 million",
    "start": "324400",
    "end": "329920"
  },
  {
    "text": "patient threshold likewise we're seeing that linking and sharing models seem to be winning right nobody has the data in",
    "start": "329920",
    "end": "337450"
  },
  {
    "text": "their own single institution or very few organizations do likewise if they do have enough patients they typically",
    "start": "337450",
    "end": "343690"
  },
  {
    "text": "don't have the molecular assets or they don't have the long-term outcomes or the patient reported outcomes that go along",
    "start": "343690",
    "end": "349330"
  },
  {
    "text": "with that and so what we can see here is that many organizations and the most successful ones have adopted models of",
    "start": "349330",
    "end": "356470"
  },
  {
    "text": "collaboration with other sources of data that have enabled them to be successful the third is that like I mentioned",
    "start": "356470",
    "end": "362890"
  },
  {
    "text": "before organizations are increasingly willing to link into share and so we're seeing many models there where these",
    "start": "362890",
    "end": "368230"
  },
  {
    "text": "organizations are entering to strategic partnerships with other data participants but yet I still think that",
    "start": "368230",
    "end": "374110"
  },
  {
    "text": "there are opportunities for advancing this frontier and specifically what I",
    "start": "374110",
    "end": "379240"
  },
  {
    "text": "find to be interesting is that there's areas of high quality imaging sort of",
    "start": "379240",
    "end": "385150"
  },
  {
    "text": "archives for radio mix and potentially odd digital pathology studies and",
    "start": "385150",
    "end": "390670"
  },
  {
    "text": "imaging right likewise I think a very interesting challenge that we have now",
    "start": "390670",
    "end": "396130"
  },
  {
    "text": "with these data sets that they've become detached from the source and oftentimes when you do a model and you find out",
    "start": "396130",
    "end": "403660"
  },
  {
    "text": "that you can predict 95% of patients having some outcome and it's a tremendous that you know result",
    "start": "403660",
    "end": "409870"
  },
  {
    "text": "to have you want to go back and say well who are the 5% I got wrong and how do I engage with them and have an",
    "start": "409870",
    "end": "415390"
  },
  {
    "text": "understanding about deeply why maybe we had them wrong - is there a mistake in the actual data source that we have it",
    "start": "415390",
    "end": "422110"
  },
  {
    "text": "was there some peculiarities out there disease or some alternative treatment pathway that we didn't capture in the",
    "start": "422110",
    "end": "427390"
  },
  {
    "text": "data set but if we talked to that patient we could understand so obviously in a way that respects patient's privacy",
    "start": "427390",
    "end": "433660"
  },
  {
    "text": "but in a way that we can also recontact these patients that's a frontier of this space that I think is extremely exciting",
    "start": "433660",
    "end": "439510"
  },
  {
    "text": "and powerful if we can figure that out so I want to sort of open up the",
    "start": "439510",
    "end": "445840"
  },
  {
    "start": "443000",
    "end": "493000"
  },
  {
    "text": "discussion here for the participants and ask you any one of a number of hint a handful of questions that have come to",
    "start": "445840",
    "end": "452050"
  },
  {
    "text": "me in a sense the first is what are your impressions of this space of real-world data you know Krishna not to single you",
    "start": "452050",
    "end": "457870"
  },
  {
    "text": "out I I know though that this has been a space that you've been a pioneer of as an investor and as bringing these",
    "start": "457870",
    "end": "463900"
  },
  {
    "text": "companies forth and helping to establish the models that can be successfully here right I'm curious you know do you think",
    "start": "463900",
    "end": "470860"
  },
  {
    "text": "that the field has progressed as much as I'm pointing out to or are we overestimating that right I mean have we",
    "start": "470860",
    "end": "476530"
  },
  {
    "text": "seen actual progress in these last few years and then furthermore what's it gonna look like in the 24 month time",
    "start": "476530",
    "end": "482500"
  },
  {
    "text": "period what are we gonna be seeing there and then lastly what are the frontiers and the most valuable to consumers that",
    "start": "482500",
    "end": "489580"
  },
  {
    "text": "we can add from where we are today who wants to start mark go ahead two data",
    "start": "489580",
    "end": "511030"
  },
  {
    "start": "493000",
    "end": "632000"
  },
  {
    "text": "sources that are I think there's examples in medicine that have been very",
    "start": "511030",
    "end": "517240"
  },
  {
    "text": "successful to answer important clinical questions and the one that I use is the Cystic Fibrosis Foundation which in many",
    "start": "517240",
    "end": "523719"
  },
  {
    "text": "ways has the same issues that multiple myeloma has which is it's a relatively rare condition you have a treatment",
    "start": "523719",
    "end": "531070"
  },
  {
    "text": "centers that are scattered over the country and the Cystic Fibrosis Foundation they invested in",
    "start": "531070",
    "end": "537440"
  },
  {
    "text": "vacation of CF centers with the requirement that they collect",
    "start": "537440",
    "end": "543770"
  },
  {
    "text": "standardized data and that everybody had to share of the data and then they were able to measure outcomes that looked at",
    "start": "543770",
    "end": "550250"
  },
  {
    "text": "the variation the end care between the different centers and so taking an outcome like colonization with",
    "start": "550250",
    "end": "556790"
  },
  {
    "text": "Pseudomonas which is a very important driver of morbidity they were able to notice that there was some very good",
    "start": "556790",
    "end": "562310"
  },
  {
    "text": "performers and some very poor performers in that data set tumor aggregated what",
    "start": "562310",
    "end": "568340"
  },
  {
    "text": "they found was that the good performers segregated new diagnosed CFA's from the patients that had had the diagnosis for",
    "start": "568340",
    "end": "574400"
  },
  {
    "text": "some time and they were able to preserve that lack of colonization for a longer period of time right some of these",
    "start": "574400",
    "end": "587900"
  },
  {
    "text": "groups the research questions that we",
    "start": "587900",
    "end": "594500"
  },
  {
    "text": "were discussing right right right interesting yeah you know this comes down to sharing",
    "start": "594500",
    "end": "599750"
  },
  {
    "text": "in some extent right I mean Orion has tried to do something I'd say is very similar to that right this is a group",
    "start": "599750",
    "end": "605000"
  },
  {
    "text": "out of the Moffitt Cancer Center they've aggregated I think over 15 organizations now that have all promised to have",
    "start": "605000",
    "end": "611420"
  },
  {
    "text": "treatment and data collection protocols that are standardized called the total cancer Cancer Care protocol and even so",
    "start": "611420",
    "end": "618770"
  },
  {
    "text": "with that infrastructure in place and with the you know collation of data they've they've had a challenge getting",
    "start": "618770",
    "end": "625160"
  },
  {
    "text": "that whole big machinery to dance and to generate consistent data they can bring into these studies and it's something",
    "start": "625160",
    "end": "630530"
  },
  {
    "text": "that it's an ongoing effort for them Krishna I saw you had your hand up before you know I think I think this has",
    "start": "630530",
    "end": "641750"
  },
  {
    "start": "632000",
    "end": "754000"
  },
  {
    "text": "got to be one of the most exciting areas in health care you know partially partially because I think of the sorts",
    "start": "641750",
    "end": "647930"
  },
  {
    "text": "of opportunities it enables in in places like multiple myeloma a variety of other",
    "start": "647930",
    "end": "653540"
  },
  {
    "text": "cancers you know but but frankly kind of across all all indications you know we",
    "start": "653540",
    "end": "659810"
  },
  {
    "text": "we kind of need this sort of real-world data in order to ask the sort of questions I think if you take the approach of figuring out some of the",
    "start": "659810",
    "end": "667190"
  },
  {
    "text": "questions that that researchers drug developers want to have I think you",
    "start": "667190",
    "end": "674360"
  },
  {
    "text": "know you come to the realization you need this longitudinal data it's always evolving especially in places like cancer the way the treatments look now",
    "start": "674360",
    "end": "680120"
  },
  {
    "text": "are different than the way they looked before you know so I you know to me I feel like the world has changed I think",
    "start": "680120",
    "end": "685160"
  },
  {
    "text": "you have 21st century cures which some people on you know in in the room here",
    "start": "685160",
    "end": "691070"
  },
  {
    "text": "have helped move forward you know you look at the work Lea's done from the payer side and you know the impact it",
    "start": "691070",
    "end": "697010"
  },
  {
    "text": "can have in that community sorry I I think I think this is a really exciting arena you know and I think you know 24",
    "start": "697010",
    "end": "704870"
  },
  {
    "text": "months from now we're gonna see a lot more exciting stuff you know coming out I think we're now in a moment we're",
    "start": "704870",
    "end": "710870"
  },
  {
    "text": "certainly the pharma universe has you know very much you know seen seen the value here right they get wasted in",
    "start": "710870",
    "end": "717470"
  },
  {
    "text": "certain pockets yeah see that yeah more and to me I think one of the areas I'm really excited about is the whole",
    "start": "717470",
    "end": "722630"
  },
  {
    "text": "patient reported outcome genre as we start to think beyond what we can get from existing systems we may not even",
    "start": "722630",
    "end": "729830"
  },
  {
    "text": "really know yet exactly what phenotypic markers are going to be really important",
    "start": "729830",
    "end": "735430"
  },
  {
    "text": "to help characterize and parse apart diseases so I think those areas are also",
    "start": "735430",
    "end": "741020"
  },
  {
    "text": "exciting and and you know in multiple myeloma and other cancers but also another non cancer education sure sure",
    "start": "741020",
    "end": "748130"
  },
  {
    "text": "sure I'm Darryl Dozier hand-up much we love to hear from you oh you seem to be muted",
    "start": "748130",
    "end": "755390"
  },
  {
    "start": "754000",
    "end": "822000"
  },
  {
    "text": "let's come back to you you can unmute Stewart let's go",
    "start": "755390",
    "end": "760000"
  },
  {
    "text": "[Music]",
    "start": "773570",
    "end": "776639"
  },
  {
    "text": "with that yeah yeah yeah absolutely",
    "start": "805020",
    "end": "810100"
  },
  {
    "text": "Darryl you want to pitch it again or um did we lose the chance to talk to you Oh still not hearing you can you guys",
    "start": "810100",
    "end": "817690"
  },
  {
    "text": "figure that out Marty yeah do you have a comment on this oh you're also having",
    "start": "817690",
    "end": "823600"
  },
  {
    "start": "822000",
    "end": "993000"
  },
  {
    "text": "problems all right Sudheer no you're not he's here he was",
    "start": "823600",
    "end": "829240"
  },
  {
    "text": "loud and clear go ahead it's always nice to see when",
    "start": "829240",
    "end": "842230"
  },
  {
    "text": "you're up on the show you give a little",
    "start": "842230",
    "end": "849970"
  },
  {
    "text": "bit too much credit to the progress and sharing so certainly there's been a number of new collaborations in this",
    "start": "849970",
    "end": "855610"
  },
  {
    "text": "space but the way the space is evolved and what it's taken from these are",
    "start": "855610",
    "end": "866770"
  },
  {
    "text": "organizations with 10 20 50 million dollars in funding these are organizations and by its very nature",
    "start": "866770",
    "end": "880750"
  },
  {
    "text": "that you know deserves a little bit of ROI for those investors and so the open",
    "start": "880750",
    "end": "886120"
  },
  {
    "text": "sharing of all of this as it comes together you know it's it's probably still a pretty big challenge when it",
    "start": "886120",
    "end": "893050"
  },
  {
    "text": "comes to open sharing versus sharing with your collaborative partner yeah just because of the sheer amount of",
    "start": "893050",
    "end": "898420"
  },
  {
    "text": "efforts I mean anyone who's done this knows the tremendous amount of effort and tens of hundreds of people that",
    "start": "898420",
    "end": "904300"
  },
  {
    "text": "needs to go into data abstraction to really do anything when it comes to to extracting real world data from from me",
    "start": "904300",
    "end": "911110"
  },
  {
    "text": "right so well you bring up a really good point and one that I think is for those of us in the space can really understand",
    "start": "911110",
    "end": "918640"
  },
  {
    "text": "and and Krishna this is an interesting dynamic right the flat-ironed two",
    "start": "918640",
    "end": "924279"
  },
  {
    "text": "billion dollar acquisition by Roche shows the value of these data sets it",
    "start": "924279",
    "end": "931089"
  },
  {
    "text": "also there's value in the pipes right the connections to patients to em ours and the system of",
    "start": "931089",
    "end": "937600"
  },
  {
    "text": "pulling it out cleaning it and making those data useful but what this does is every other data holder now says my data",
    "start": "937600",
    "end": "944650"
  },
  {
    "text": "are gold and I need to make sure I'm getting close to my two billion dollars worth of mine and so there's always this",
    "start": "944650",
    "end": "950350"
  },
  {
    "text": "question about well what where's the value is the value in the data or in the pipes because a lot of people have data",
    "start": "950350",
    "end": "956760"
  },
  {
    "text": "flatiron also built the pipes and I think that's a really interesting dynamic is that the ability to",
    "start": "956760",
    "end": "961810"
  },
  {
    "text": "seamlessly get data from a large community of physicians with patients being treated today and with a short",
    "start": "961810",
    "end": "968410"
  },
  {
    "text": "latency being able to look at those data and make a decision about how treatments are being used and outcomes are changing",
    "start": "968410",
    "end": "974080"
  },
  {
    "text": "because as we know treatments are changing all the time outcomes are changing all the time standard of care is changing all the time",
    "start": "974080",
    "end": "979960"
  },
  {
    "text": "so if we have a high latency system with let's say slow pipes and slow you know",
    "start": "979960",
    "end": "985540"
  },
  {
    "text": "progress through those pipes we can't actually have the insights that can can continually evolve care yeah sure",
    "start": "985540",
    "end": "994330"
  },
  {
    "start": "993000",
    "end": "1051000"
  },
  {
    "text": "exactly I'm Brad coming from you patient",
    "start": "994330",
    "end": "1038339"
  },
  {
    "text": "certainly wanted that's for sure so let me continue if we can because we have a lot more content to go through and then",
    "start": "1038339",
    "end": "1043380"
  },
  {
    "text": "we're gonna have another opportunity for questions also and discussion after we go through the analytics aspect so like",
    "start": "1043380",
    "end": "1050040"
  },
  {
    "text": "I said at the beginning in addition to landscaping up the data and the real-world data of oncology we also have",
    "start": "1050040",
    "end": "1056580"
  },
  {
    "start": "1051000",
    "end": "1131000"
  },
  {
    "text": "increasingly been finding stakeholders asking us well who are the analytics providers out there how do they stack up",
    "start": "1056580",
    "end": "1062670"
  },
  {
    "text": "against each other what aspects are we able to sort of say our system is systematically being addressed by these",
    "start": "1062670",
    "end": "1068730"
  },
  {
    "text": "analytics companies and so we put a lot of for over the past about six or eight months and trying to survey this space",
    "start": "1068730",
    "end": "1075030"
  },
  {
    "text": "understand who's out there and see what we can learn right obviously there's been a lot of headlines and you know",
    "start": "1075030",
    "end": "1081120"
  },
  {
    "text": "pixels devoted to the advent of these analytics companies and the opportunities that AI can provide not",
    "start": "1081120",
    "end": "1087390"
  },
  {
    "text": "just in healthcare but beyond healthcare and that's I think made for a tremendous amounts of excitement behind this space",
    "start": "1087390",
    "end": "1093270"
  },
  {
    "text": "at the same hand though there's been tremendous confusion uncertainty and to some point actually downright",
    "start": "1093270",
    "end": "1099059"
  },
  {
    "text": "disappointment about the ability of these technologies to deliver on healthcare today right I mean for a long",
    "start": "1099059",
    "end": "1104909"
  },
  {
    "text": "time now healthcare has been in some ways a laughingstock of the AI space because we've been so inept in trying to",
    "start": "1104909",
    "end": "1111809"
  },
  {
    "text": "bring a AI technology into the healthcare environment right so we can",
    "start": "1111809",
    "end": "1116880"
  },
  {
    "text": "get into it it's a whole nother conversation but to say you know in many ways people want understand what's out there and you know where are the the",
    "start": "1116880",
    "end": "1124020"
  },
  {
    "text": "places that are most likely to be valuable as a consumer as an investor as somebody who's trying to help push this",
    "start": "1124020",
    "end": "1129690"
  },
  {
    "text": "space ahead so what we did is we recognized that there's a tremendous number of companies in this space in",
    "start": "1129690",
    "end": "1136049"
  },
  {
    "start": "1131000",
    "end": "1622000"
  },
  {
    "text": "fact some really sophisticated people we'd speak to when we told them that we found 65 companies that are in this",
    "start": "1136049",
    "end": "1142260"
  },
  {
    "text": "space they were actually downright surprised that we were able to find so many companies there right and so what's",
    "start": "1142260",
    "end": "1148770"
  },
  {
    "text": "interesting is what we did is we asked you know for all the different stakeholders there's some fundamental questions they want to know who should I",
    "start": "1148770",
    "end": "1154950"
  },
  {
    "text": "partner with who should I invest in should I buy the technology I need or should I build it right what are the",
    "start": "1154950",
    "end": "1161460"
  },
  {
    "text": "most mature technologies that maybe are going to end up in the clinic in the next five years and how do I know which ones those are and so we sought to",
    "start": "1161460",
    "end": "1167549"
  },
  {
    "text": "answer some of these questions by providing some metrics around this space to look at how these companies stacked",
    "start": "1167549",
    "end": "1173460"
  },
  {
    "text": "up this is a list of the 48 companies we included in our final analysis you can",
    "start": "1173460",
    "end": "1178919"
  },
  {
    "text": "tell here they're sort of across the board a lot of these companies are based in the US but there are some European",
    "start": "1178919",
    "end": "1184230"
  },
  {
    "text": "players as well we had to remove companies that had two hallmarks one is",
    "start": "1184230",
    "end": "1189360"
  },
  {
    "text": "that they were too complex so companies like a flatiron or an IBM or like lluvia while they have analytic capabilities",
    "start": "1189360",
    "end": "1196169"
  },
  {
    "text": "it's hard to judge from the outside how much those analytics capabilities are driving and delivering value today",
    "start": "1196169",
    "end": "1201330"
  },
  {
    "text": "obviously these companies are major players of me don't want suggests that they could be ignored but they're just hard to put into our",
    "start": "1201330",
    "end": "1207570"
  },
  {
    "text": "analysis and likewise there's many companies that are just emerging in this space and there's just insufficient",
    "start": "1207570",
    "end": "1212940"
  },
  {
    "text": "publicly available data on what they're doing how they're doing it and the progression that they're seeing in their platform so several companies about 17",
    "start": "1212940",
    "end": "1220890"
  },
  {
    "text": "or so we had to remove from the analysis as well what we notice is that there's",
    "start": "1220890",
    "end": "1226140"
  },
  {
    "text": "essentially three different large buckets of preclinical clinical and clinical research and clinical care that",
    "start": "1226140",
    "end": "1232500"
  },
  {
    "text": "these applications fall into and specifically about six use cases within there from drug discovery to biomarker",
    "start": "1232500",
    "end": "1239910"
  },
  {
    "text": "and target ID clinical trial access and clinical trial patient identification sorry clinical trial analysis was the",
    "start": "1239910",
    "end": "1247169"
  },
  {
    "text": "first one and then lastly population and value based healthcare solutions as well as clinical pathways and decision",
    "start": "1247169",
    "end": "1253140"
  },
  {
    "text": "support and so what we did we did an analysis on each of these buckets as well and the method we used was we",
    "start": "1253140",
    "end": "1259530"
  },
  {
    "text": "looked at to what extent we can see that companies are either accelerating or established and we looked at the",
    "start": "1259530",
    "end": "1266429"
  },
  {
    "text": "acceleration of a companies by how much financing they received between April 2017 and April 2018 the percentage of",
    "start": "1266429",
    "end": "1273510"
  },
  {
    "text": "job growth that their experiences or how many head counts are they adding and then the percent of open positions at",
    "start": "1273510",
    "end": "1278760"
  },
  {
    "text": "the time when we looked at them in the April period so we asked fundamentally are these companies looking for a much",
    "start": "1278760",
    "end": "1284100"
  },
  {
    "text": "brighter trajectory in the 2018 to 2019 period likewise in terms of",
    "start": "1284100",
    "end": "1289260"
  },
  {
    "text": "establishment we asked well how many publications or case studies can they have they put their name on and they can",
    "start": "1289260",
    "end": "1294299"
  },
  {
    "text": "point to as successes how many partners partners or customers are they speaking publicly about working with and of",
    "start": "1294299",
    "end": "1300690"
  },
  {
    "text": "course did you know how much financing has the investment community found to put into their effort and and behind",
    "start": "1300690",
    "end": "1306840"
  },
  {
    "text": "them and obviously with these two dimensions and of course who doesn't love a good two by two we're sitting here at Harvard Business School right we",
    "start": "1306840",
    "end": "1313799"
  },
  {
    "text": "have here in a sense now we can look at companies as in regardless two by two and you can see the upper white right",
    "start": "1313799",
    "end": "1320160"
  },
  {
    "text": "quadrant is they are these hot companies and these are the companies that both have an established track record but are",
    "start": "1320160",
    "end": "1325559"
  },
  {
    "text": "also growing in a tremendously fast pace and therefore representing companies that I think are in a really good",
    "start": "1325559",
    "end": "1330720"
  },
  {
    "text": "position to build on what they've done so far and are showing that acceleration and momentum in the future now I'll be",
    "start": "1330720",
    "end": "1338220"
  },
  {
    "text": "the first to say this methodology while it was something that Richard and I cooked up I think on a rainy you know March",
    "start": "1338220",
    "end": "1344040"
  },
  {
    "text": "afternoon you know it is limited right we're very us focused in what we do we",
    "start": "1344040",
    "end": "1349080"
  },
  {
    "text": "have limited accuracy with both large and small companies we are you know able",
    "start": "1349080",
    "end": "1355170"
  },
  {
    "text": "to quantify the companies as a whole but not necessarily their specific capabilities because that's even more",
    "start": "1355170",
    "end": "1361710"
  },
  {
    "text": "granular than we can get into this is also a trailing indicator you know already having the analysis end in April",
    "start": "1361710",
    "end": "1368790"
  },
  {
    "text": "2018 we're limited by what we can conclude there and lastly this may fail to capture some of the breakthrough",
    "start": "1368790",
    "end": "1374820"
  },
  {
    "text": "innovations that are occurring by these companies that are paradigm shifting or very different in what they're what",
    "start": "1374820",
    "end": "1380220"
  },
  {
    "text": "they're doing um so this is the way the 2x2 shows up when you actually look at",
    "start": "1380220",
    "end": "1385440"
  },
  {
    "text": "the results um you can see here these companies fall nicely across the spectrum we normalize everything by",
    "start": "1385440",
    "end": "1391410"
  },
  {
    "text": "percentiles so those middle lines represent the fiftieth percentile and you can see here not surprisingly that",
    "start": "1391410",
    "end": "1397200"
  },
  {
    "text": "companies tend to scatter in the top left which are the established companies that tend to be accelerating a little",
    "start": "1397200",
    "end": "1402570"
  },
  {
    "text": "bit of a slower pace and the bottom right which tend to be the companies that are small and growing fast and not",
    "start": "1402570",
    "end": "1409500"
  },
  {
    "text": "necessarily established yet but showing tremendous amount of growth over the last year the top right companies though",
    "start": "1409500",
    "end": "1416160"
  },
  {
    "text": "I think are the ones of tremendous interest and so what I'm gonna do is go through each of the different use cases and highlight some of those companies",
    "start": "1416160",
    "end": "1421860"
  },
  {
    "text": "and what they're doing so the first is whooshing next code I don't know for folks have heard of them they're a big",
    "start": "1421860",
    "end": "1428220"
  },
  {
    "text": "player in the CRO space and coming out of China they actually have 240 million dollar investment in the past year and",
    "start": "1428220",
    "end": "1435270"
  },
  {
    "text": "there you know regarded as one of the most innovative companies in their space right likewise tempest tempest came from",
    "start": "1435270",
    "end": "1441330"
  },
  {
    "text": "I wouldn't even try to say Eric's last name but the founder of Groupon formulated and came up with Tempest they",
    "start": "1441330",
    "end": "1448170"
  },
  {
    "text": "in license the ASCO cancer link data asset and now they've actually been putting tremendous amounts of analytics",
    "start": "1448170",
    "end": "1453630"
  },
  {
    "text": "on top of that and they just put a series B 80 million dollars into their coffers and I believe they've already",
    "start": "1453630",
    "end": "1460110"
  },
  {
    "text": "even reached unicorn status in less than two or three years of since founding and they've announced over 40 partnerships",
    "start": "1460110",
    "end": "1466380"
  },
  {
    "text": "actually last days recursion Pharma which received a tremendous amount of funding and as",
    "start": "1466380",
    "end": "1471870"
  },
  {
    "text": "Big Pharma relationships that I think is also quite interesting these are of course the companies in the biomarker",
    "start": "1471870",
    "end": "1477990"
  },
  {
    "text": "and target discovery space another few to mention here a drug discovery new",
    "start": "1477990",
    "end": "1483840"
  },
  {
    "text": "Medi is a company out in the Bay Area actually it's founded by the wife of Atul Butte who's a famed professor out",
    "start": "1483840",
    "end": "1490770"
  },
  {
    "text": "there as well and these guys have tremendous numbers of partnerships with pharma companies a whole bunch of",
    "start": "1490770",
    "end": "1496320"
  },
  {
    "text": "publications and they're also sort of emerging on the scene as a really interesting and hot player with regard",
    "start": "1496320",
    "end": "1501990"
  },
  {
    "text": "to sort of analytics based drug discovery technologies FDA comes up as a",
    "start": "1501990",
    "end": "1509400"
  },
  {
    "text": "company that's really hot in the space of clinical trial patient ID interestingly they have what I would",
    "start": "1509400",
    "end": "1514710"
  },
  {
    "text": "consider pretty breakthrough technology they're looking at analytics of the facial composition the facial phenotype",
    "start": "1514710",
    "end": "1520650"
  },
  {
    "text": "as the means of understanding rare disease diagnosis and then they can use this for that aisle bringing patients",
    "start": "1520650",
    "end": "1526470"
  },
  {
    "text": "into clinical trials these rare diagnoses are incredibly hard to diagnose and therefore many times",
    "start": "1526470",
    "end": "1531990"
  },
  {
    "text": "patients lose the opportunity to participate in trials because they're not well diagnosed a I cure is a company",
    "start": "1531990",
    "end": "1539550"
  },
  {
    "text": "at standing up in the clinical trial analysis space and this is again a really interesting company that I think",
    "start": "1539550",
    "end": "1545040"
  },
  {
    "text": "is doing some fantastic stuff they have over a hundred patents either pending or",
    "start": "1545040",
    "end": "1550830"
  },
  {
    "text": "registered already and they have experienced tremendous growth in the past year growing about 50% in terms of",
    "start": "1550830",
    "end": "1557730"
  },
  {
    "text": "headcount just a few more and then we can go on I as Dee is a company that is",
    "start": "1557730",
    "end": "1563070"
  },
  {
    "text": "showing up here a lot as well in the clinical pathways and decision support systems these guys are trying to use a",
    "start": "1563070",
    "end": "1568860"
  },
  {
    "text": "new visualization technology to understand the variations in care and how those different variations can",
    "start": "1568860",
    "end": "1575670"
  },
  {
    "text": "suggest are improvements to pathways and then lastly I'll call out coda which",
    "start": "1575670",
    "end": "1581610"
  },
  {
    "text": "stands up and nice to have Stewart with us here from coda actually they just raised 40 million dollars and they work",
    "start": "1581610",
    "end": "1587280"
  },
  {
    "text": "closely with many leading institutions including Memorial sloan-kettering and they've shown up also as tremendously",
    "start": "1587280",
    "end": "1592710"
  },
  {
    "text": "exciting population health and and and value-based care analytics company so",
    "start": "1592710",
    "end": "1599429"
  },
  {
    "text": "with this and recognizing a few minutes left and I know I just flew through that material we're gonna send out the slides",
    "start": "1599429",
    "end": "1604710"
  },
  {
    "text": "afterwards but I want to ask what are your general reactions did you see any companies here that you know that that we missed and",
    "start": "1604710",
    "end": "1612330"
  },
  {
    "text": "how do you think that this space is going to be evolving in the next 24 months and so you know let me open it up",
    "start": "1612330",
    "end": "1618630"
  },
  {
    "text": "for questions who wants to either raise a question make a comment all right",
    "start": "1618630",
    "end": "1628429"
  },
  {
    "start": "1622000",
    "end": "1772000"
  },
  {
    "text": "Krishna thank you yes I think it's a",
    "start": "1628429",
    "end": "1637200"
  },
  {
    "text": "great framework and I think it helpful way to look at all those companies you",
    "start": "1637200",
    "end": "1642899"
  },
  {
    "text": "know one of the one of the things I think we've I think it came out in the discussion you know and I think it was",
    "start": "1642899",
    "end": "1648299"
  },
  {
    "text": "maybe a clay Christensen framework from back in business school where he talked about you know how all the profits end",
    "start": "1648299",
    "end": "1654149"
  },
  {
    "text": "up you know aggregating around the hardest part of some pipeline you know I think the group identified you know data",
    "start": "1654149",
    "end": "1660240"
  },
  {
    "text": "right now as maybe the hardest part of the pipeline is Ivy I think you know we see a lot of analytics companies but in",
    "start": "1660240",
    "end": "1666120"
  },
  {
    "text": "the end the data is still kind of prerequisite to me it feels like that's why you know healthcare always looks so",
    "start": "1666120",
    "end": "1671789"
  },
  {
    "text": "behind in some of these areas is that you know you kind of go to some of the end like like kind of the larger",
    "start": "1671789",
    "end": "1678200"
  },
  {
    "text": "analytics firms on the data you know I'm the data Sciences side and it's like you know you compare this sort of data we",
    "start": "1678200",
    "end": "1684779"
  },
  {
    "text": "have an ad tech or you know or social networking or something you know relative to clinical medicine we're",
    "start": "1684779",
    "end": "1689850"
  },
  {
    "text": "still kind of not yet we don't have that first step but once we do I think all these really exciting things start to",
    "start": "1689850",
    "end": "1697350"
  },
  {
    "text": "unlock so to me at least you know I think it's a great framework I think it's really good analysis on it you know",
    "start": "1697350",
    "end": "1704970"
  },
  {
    "text": "to me as I look at it you know all the values really at least today and just getting to step one right we're kind of",
    "start": "1704970",
    "end": "1711090"
  },
  {
    "text": "just like you're not yet at the point where we can really apply like you know really all the exciting data scientist",
    "start": "1711090",
    "end": "1717000"
  },
  {
    "text": "stuff to it and that's me it kind of speaks a little bit to why there's not",
    "start": "1717000",
    "end": "1723269"
  },
  {
    "text": "so many exits and in certain categories yeah there ya know those are very good",
    "start": "1723269",
    "end": "1728850"
  },
  {
    "text": "points to be made I kind of think this as as there's a first mile problem in a last mile problem the first mile problem",
    "start": "1728850",
    "end": "1734909"
  },
  {
    "text": "is getting the raw materials to feed into these algorithms and platforms and that's the data to and the last mile is translating them",
    "start": "1734909",
    "end": "1741510"
  },
  {
    "text": "into changes in clinical practice right and how do we impact clinical practice or how do we go invest in a drug",
    "start": "1741510",
    "end": "1747630"
  },
  {
    "text": "discovery or drug development program from molecule that a computer built right you know and so all these things",
    "start": "1747630",
    "end": "1753300"
  },
  {
    "text": "are our translations come here to them as well but but I guess the question for you Krishna sitting there on an",
    "start": "1753300",
    "end": "1758430"
  },
  {
    "text": "investment side if we are seeing progress on the data side if there are now multiple viable models that have a",
    "start": "1758430",
    "end": "1764970"
  },
  {
    "text": "million-plus patients in the real world evidence space you know at what point how will you know that the tides have",
    "start": "1764970",
    "end": "1771120"
  },
  {
    "text": "shifted and that the new crux of the problem is on the analytics side and not necessarily held up anymore by the data",
    "start": "1771120",
    "end": "1777990"
  },
  {
    "start": "1772000",
    "end": "1897000"
  },
  {
    "text": "side approaching some of these things",
    "start": "1777990",
    "end": "1790470"
  },
  {
    "text": "from a domain which is not oriented around data you know then it can sometimes seem like the more esoteric",
    "start": "1790470",
    "end": "1796140"
  },
  {
    "text": "more challenging part of it because people talk about computational topology or kernel networks and folks often don't",
    "start": "1796140",
    "end": "1801840"
  },
  {
    "text": "know what those are but but I don't think those are really the bottlenecks right now in point of fact many of those techniques are open source you know I",
    "start": "1801840",
    "end": "1808710"
  },
  {
    "text": "think that's the way a lot of the data Sciences companies certainly that's the way Google is approaching it all the cool stuff they're developing they're",
    "start": "1808710",
    "end": "1814770"
  },
  {
    "text": "releasing them to the public they're publishing oh yeah almost all of it and it's you know to me I think the way that",
    "start": "1814770",
    "end": "1821370"
  },
  {
    "text": "we know that we're there you know is actually I mean it's it's when we start to really see cures or deep impact you",
    "start": "1821370",
    "end": "1829170"
  },
  {
    "text": "know in the diseases so to me that's all about developing the drug that's non-trivial to do that's really scary to",
    "start": "1829170",
    "end": "1834780"
  },
  {
    "text": "data Sciences people to actually develop the drug but it's you know people do it and and to me I think you know the time",
    "start": "1834780",
    "end": "1843750"
  },
  {
    "text": "when I feel like we'll see some significant shift in the industry is when somebody can say well you know in a",
    "start": "1843750",
    "end": "1849450"
  },
  {
    "text": "similar case so like pcsk9 let's say where there was some data oriented approach to identifying an interesting",
    "start": "1849450",
    "end": "1854730"
  },
  {
    "text": "target that was then actually you know you know targeted obviously payment issues on the other",
    "start": "1854730",
    "end": "1859860"
  },
  {
    "text": "end of it you know but but you know when we see that sort of story carry through and cancer or some of there's not once",
    "start": "1859860",
    "end": "1865740"
  },
  {
    "text": "not twice probably a multitude of times you know before people can say well all",
    "start": "1865740",
    "end": "1870750"
  },
  {
    "text": "the value isn't in the drug it's not even in the data it's like it you know it's it's you know it's now",
    "start": "1870750",
    "end": "1877480"
  },
  {
    "text": "somewhere in the analysis and and and the array of interesting questions to be asked interesting I think we see that in",
    "start": "1877480",
    "end": "1883300"
  },
  {
    "text": "other areas yeah but I don't think the world believes that that's the case today I missus been told before in",
    "start": "1883300",
    "end": "1890080"
  },
  {
    "text": "healthcare people are skeptical you have not been you okay yeah mark let's",
    "start": "1890080",
    "end": "1896620"
  },
  {
    "text": "go to you you have a comment or a question with the question to one of the",
    "start": "1896620",
    "end": "1912130"
  },
  {
    "start": "1897000",
    "end": "1992000"
  },
  {
    "text": "other participants new comer to me",
    "start": "1912130",
    "end": "1916740"
  },
  {
    "text": "actually you know or something of that nature and so to some degree I was a",
    "start": "1920970",
    "end": "1927730"
  },
  {
    "text": "little bit surprised to see Regeneron not up on the matrix there of course that self-interested since we're",
    "start": "1927730",
    "end": "1933640"
  },
  {
    "text": "partnering with them but they also are dealing with the UK so I think I can snug completely self-interested but to",
    "start": "1933640",
    "end": "1940240"
  },
  {
    "text": "me a lot of this has to do with how do",
    "start": "1940240",
    "end": "1946390"
  },
  {
    "text": "we improve the clinical care develop a new drug improve the delivery of the",
    "start": "1946390",
    "end": "1968410"
  },
  {
    "text": "methods we have the medicine yeah I'm",
    "start": "1968410",
    "end": "1983320"
  },
  {
    "text": "not sure we have Lee here anymore right just see his picture so we do he's having a technical problem or he had to",
    "start": "1983320",
    "end": "1988450"
  },
  {
    "text": "depart so I wish he was here to answer that that would be a fantastic conversation I'd love to see here you",
    "start": "1988450",
    "end": "1999130"
  },
  {
    "start": "1992000",
    "end": "2047000"
  },
  {
    "text": "know definitive cures or impact to diseases through drug discovery you know",
    "start": "1999130",
    "end": "2004440"
  },
  {
    "text": "can create I think huge amounts in the system and it can also be the case as I think it is that there's huge",
    "start": "2004440",
    "end": "2010560"
  },
  {
    "text": "amounts of waste in the system it's very challenging to get innovation to patients it's challenging to figure out you know how to pay for any of that yeah",
    "start": "2010560",
    "end": "2017670"
  },
  {
    "text": "and both the idea I think both things are true that's why it's complicated you",
    "start": "2017670",
    "end": "2022710"
  },
  {
    "text": "know and then and then we can ask the question of like you know if you have to stack rank and pick one or the other which one would you pick but we happen to be in the world where",
    "start": "2022710",
    "end": "2028770"
  },
  {
    "text": "there there seems to be at least today enough money around the system that we can you know walk and chew gum at the",
    "start": "2028770",
    "end": "2034500"
  },
  {
    "text": "same time and you know do both care innovation and that was you know drug discovery at least for now but it seems",
    "start": "2034500",
    "end": "2042540"
  },
  {
    "text": "like robots markets um Brian I see you have a question we only have five more minutes so maybe one after Brian go ahead Brian",
    "start": "2042540",
    "end": "2049730"
  },
  {
    "start": "2047000",
    "end": "2090000"
  },
  {
    "text": "learning from experiences of patients and getting that learning back out it was commented earlier I mean obviously",
    "start": "2054020",
    "end": "2060658"
  },
  {
    "text": "the most expensive part about drug development is the clinical evidence generation and so you know be having",
    "start": "2060659",
    "end": "2067050"
  },
  {
    "text": "these systems that are able to kind of collect data and analyzed in an efficient way makes that process much more affordable",
    "start": "2067050",
    "end": "2073200"
  },
  {
    "text": "and you can unlock a lot of innovation but it also is the same system that you",
    "start": "2073200",
    "end": "2078360"
  },
  {
    "text": "get those learnings back out to patients yeah yeah change care change care Bob all right well thank you everybody for",
    "start": "2078360",
    "end": "2084690"
  },
  {
    "text": "the time today and",
    "start": "2084690",
    "end": "2088190"
  }
]